Showing results (81-90 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|December 1, 1991
5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviourD Baldwin, T Bullock, D Montgomery, et al.International Clinical Psychopharmacology|April 15, 2008
The GRID-HAMD: standardization of the Hamilton Depression Rating ScaleJanet B W Williams, Kenneth A Kobak, Per Bech, et al.International Clinical Psychopharmacology|April 15, 2008
Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetineMadhukar H Trivedi, Durisala Desaiah, Melissa J Ossanna, et al.International Clinical Psychopharmacology|May 27, 2025
Agranulocytosis after long-term clozapine use: a case reportAgostina Secchi, Madelaine Bridges, Eromona Whiskey, et al.International Clinical Psychopharmacology|January 29, 2026
An observational study on the effects of as-needed use of various antipsychotic drugs for agitation due to psychotic disordersKotaro Hatta, Fumiyoshi Morikawa, Satoshi Yamasaki, et al.International Clinical Psychopharmacology|October 23, 2003
Reducing the dose of antipsychotic medications for those who had been treated with high-dose antipsychotic polypharmacy: an open study of dose reduction for chronic schizophreniaTakefumi Suzuki, Hiroyuki Uchida, Kenji F Tanaka, et al.International Clinical Psychopharmacology|October 23, 2003
Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case reportE Sacchetti, P ValsecchiInternational Clinical Psychopharmacology|November 1, 1992
The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderlyJ S Kerr, D B Fairweather, R Mahendran, et al.International Clinical Psychopharmacology|November 1, 1992
Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoatesS McLaren, J C Cookson, T SilverstoneInternational Clinical Psychopharmacology|November 1, 1992
The calcium channel antagonist nifedipine causes confusion when used to treat opiate withdrawal in morphine-dependent patientsP H Silverstone, M J Attenburrow, P RobsonPageof 212